Indolidone derivatives for the treatment or prevention of fibrotic diseases

Details for Australian Patent Application No. 2005318126 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Park, John, Edward; Dahmann, Georg; Heckel, Armin; Grauert, Matthias; Brandl, Trixi; Roth, Gerald Jurgen; Chaudhary, Nveed

Agent Davies Collison Cave

Pub. Number AU-B-2005318126

PCT Pub. Number WO2006/067165

Priority 04030770.4 24.12.04 EP

Filing date 21 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 24 November 2011

International Classifications

A61K 31/404 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/067165 Priority application(s): WO2006/067165

24 November 2011 Application Accepted

  Published as AU-B-2005318126

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005318130-Method of preparing catalyst support from a waste catalyst

2005318122-Process for the preparation of crosslinked PBT particles